This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Roots Analysis has conducted an exhaustive study on In Vitro Diagnostics Market featuring the current market landscape and future opportunity for the companies engaged in offering in vitro diagnostic solutions, over a span of 11 years. The figure pasted below shows a summarized representation of SWOT points affiliated with IVD Market.
New data from the Plant Based Foods Association (PBFA) and The Good Food Institute (GFI) shows that the retail sales of plant-based foods in the US grew by 27 percent in 2020, bringing its total market value to $7 billion. of the $7 billion market. Plant-Based Milk Sales. Plant-Based Meat Sales. billion in sales in 2020.
It has since expanded nationwide, threatening an important market for many Big Pharma players. . At the time, Wolfe Researchanalyst Tim Anderson wondered whether the decline was the “canary in the coalmine” for the rest of the industry, which has been relying on the lucrative China market for revenue growth.
This article explores the role of molecular diagnostics in early cancer detection, highlighting the benefits and future prospects in the oncology molecular diagnostics market. A growing sub-segment of the overall market is oncology molecular diagnostics market, which is helping fill the unmet need for early diagnosis.
Jakub Hlávka, PhD, the executive director of the Healthcare Markets Initiative and Fellow at the University of Southern California Schaeffer Center, suggests the strategy behind this new warranty program could “minimise the [financial and clinical] risk for the provider and for the patient”.
Prior to that, Zhang was an equity researchanalyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,
It is worth mentioning that molecular diagnostics is a subset of the broader in vitro diagnostics market. According to the World Health Organization, there are over 40,000 in vitro diagnostics products available in the market. To date, he has contributed to over eight full length marketresearch projects and consulting projects.
“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior ResearchAnalyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.
With the rising demand for antibody therapeutics in the recent past, the domain of antibody discovery has seen a significant market growth towards outsourcing. Companies are now turning to contract research organizations to help accelerate their workflow. To date, he has contributed to over seven full length marketresearch projects.
The peptide therapeutics market has undergone substantial evolution since the inception of insulin. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases.
Synthetic Leather Manufacturers – Current Market Landscape The synthetic leather industry landscape in healthcare features over 235 players offering various synthetic leather, with different formulation, function and serving variety of end-users. The figure pasted below shows a summarized representation of SWOT points mentioned above.
“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior ResearchAnalyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.
Prior to that, Dr. Zhang was an equity researchanalyst at UBS in New York , where he covered the Major and Specialty Pharmaceutical Sector. in its healthcare practice and conducted postdoctoral research in diabetes-related drug development at Boston University’s School of Medicine.
Strategic Relationships: This parameter represents the strategic alliances, partners, or a burgeoning customer base in order to evaluate the marketing risks of a start-up. As a senior analyst at Roots Analysis, Gaurav has assisted several clients across multiple industry verticals within the healthcare domain.
Author’s Bio Akarshika Singh is a business researchanalyst and competitive intelligence professional. As an experienced analyst at Roots Analysis, Akarshika has assisted several clients across multiple industry verticals within the healthcare domain.
Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal researchanalyst, at a recent webinar on the same topic. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.
Approved Subcutaneous Biologics Market Analysis: Current Landscape The subcutaneous biologics market analysis for approved drugs presents over 175 subcutaneous biologics developed by around 50 drug developers, worldwide. Further, the majority of the companies in the approved market are presently headquartered in North America.
The recent advancements in the field of protein expression, coupled with the launch of novel expression systems have emerged as the key drivers for the growing adoption of protein expression solutions in the overall pharma market. Want additional details on the market? Access our Protein Expression Market Report.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content